Equities

Belluscura PLC

BELL:LSE

Belluscura PLC

Health CareMedical Equipment and Services
  • Price (GBX)7.75
  • Today's Change0.00 / 0.00%
  • Shares traded99.06k
  • 1 Year change-80.38%
  • Beta--
Data delayed at least 20 minutes, as of Apr 26 2024 15:10 BST.
More ▼

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Belluscura PLC had net income fall 56.38% from a loss of 5.21m to a larger loss of 8.15m despite a 232.62% increase in revenues from 420.32k to 1.40m. An increase in the cost of goods sold as a percentage of sales from 112.41% to 159.52% was a component in the falling net income despite rising revenues.
Gross margin-32.24%
Net profit margin-831.69%
Operating margin-811.79%
Return on assets-36.98%
Return on equity-40.83%
Return on investment-40.59%
More ▼

Cash flow in USDView more

In 2022, cash reserves at Belluscura PLC fell by 13.84m. Cash Flow from Financing totalled 7.29m or 521.30% of revenues. In addition the company used 14.91m for operations while cash used for investing totalled 5.08m.
Cash flow per share-0.0539
Price/Cash flow per share--
Book value per share0.1487
Tangible book value per share0.0882
More ▼

Balance sheet in USDView more

Belluscura PLC uses little or no debt in its capital structure.
Current ratio8.89
Quick ratio4.17
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.